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Compound heterozygous mutationsHypophosphatasia (HPP) is an inherited disorder of mineral metabolism caused by mutations in ALPL, encoding
tissue non-speciﬁc alkaline phosphatase (TNAP). Here, we report the molecular ﬁndings from monozygotic
twins, clinically diagnosedwith tooth-speciﬁc odontohypophosphatasia (odonto-HPP). Sequencing ofALPL iden-
tiﬁed two genetic alterations in the probands, including a heterozygousmissensemutation c.454C>T, leading to
change of arginine 152 to cysteine (p.R152C), and a novel heterozygous gene deletion c.1318_1320delAAC, lead-
ing to the loss of an asparagine residue at codon 440 (p.N440del). Clinical identiﬁcation of low serum TNAP ac-
tivity, dental abnormalities, and pedigree data strongly suggests a genotype–phenotype correlation between
p.N440del and odonto-HPP in this family. Computational analysis of the p.N440del protein structure revealed
an alteration in the tertiary structure affecting the collagen-binding site (loop 422–452), which could potentially
impair the mineralization process. Nevertheless, the probands (compound heterozygous: p.[N440del];[R152C])
feature early-onset and severe odonto-HPP phenotype, whereas the father (p.[N440del];[=]) has onlymoderate
symptoms, suggesting p.R152Cmay contribute or predispose to amore severe dental phenotype in combination
with the deletion. These results assist in deﬁning the genotype–phenotype associations for odonto-HPP, and
further identify the collagen-binding site as a region of potential structural importance for TNAP function in
the biomineralization.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Hypophosphatasia (HPP; OMIM ID: 146300, 241500, 241510) is a
rare metabolic inherited disorder characterized by defective mineraliza-
tion of bones and teeth due to deﬁcient enzymatic activity of tissue
non-speciﬁc alkaline phosphatase (TNAP) [1]. Disease symptoms are
highly variable in their clinical expression, and six clinical forms are cur-
rently recognized, based on age at diagnosis and severity of features, in-
cluding: lethal perinatal, benign perinatal, infantile, childhood, adult, and
odontohypophosphatasia (odonto-HPP) forms [2]. The birth prevalence
of the most severe forms of HPP, i.e. perinatal and infantile, is estimated
to be 1:100,000. On the basis of frequency of heterozygotes anderms of the Creative Commons
icense, which permits non-
medium, provided the original
tics and Periodontics, Division
01, 13414-903, Piracicaba, SP,
blished by Elsevier Inc. All rights reproportion of mutations exhibiting a dominant negative effect, it is
expected that mild forms of HPP (childhood, adult and odonto-HPP)
are more common than severe forms [3].
All clinical isotypes of HPP, including odonto-HPP, share in com-
mon reduced serum TNAP activity (ALP), and presence of either one
or two pathologic mutations in the ALPL gene [3]. The ALPL gene
(OMIM ID: 171760) is mapped to chromosome 1 (1p36.12) and con-
sists of 12 exons encoding TNAP [4]. Currently, at least 264 distinct
mutations and 16 polymorphisms in the ALPL gene have been identi-
ﬁed and associated with various forms of HPP. Missense mutations
account for 75% of these mutations, while the remaining percentage
are represented by small deletions (11%), splicing mutations (5.7%),
nonsense mutations (3.8%), small insertions (2.3%), large deletions
(1.1%), insertions or deletions (0.7%), and mutations in regulatory
ALPL sequences (0.4%) (http://www.sesep.uvsq.fr/03_hypo_mutations.
php#stat). In milder forms, in which one mutant allele is believed to
be sufﬁcient to cause disease, mutation detection rate is more difﬁcult
to estimate [3].
Deﬁcient TNAP activity is thought to be the major cause for skele-
tal mineralization defects observed in HPP [1,5]. TNAP regulates min-
eralization by hydrolyzing the mineralization inhibitor, inorganicserved.
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locally which participates in propagation of hydroxyapatite crystals
in the extracellular matrix, and in deposition of hydroxyapatite be-
tween collagen ﬁbrils [1,5]. Decrease or loss of TNAP activity leads
to accumulation of extracellular PPi, provided in part by nucleotide
pyrophosphatase phosphodiesterase 1 (NPP1) and progressive anky-
losis protein homolog (ANKH), resulting in inhibition of hydroxyapa-
tite formation [5–7].
TNAP is reported to be a dimeric structure on the cell surface, linked
to the membrane via glycosylphosphatidylinositol (GPI) anchors, and
oriented so that the active sites face the extracellular environment. The
enzyme is also active as a homodimer but not as a monomer [8,9]. Due
to the structural properties of the TNAP, some mutations affecting pro-
tein structure may exhibit a dominant negative effect. These dominant
negative mutations (also called antimorphic mutations) usually result
in an altered molecular function due to inhibition of enzymatic activity
of the normal monomer by the mutated partner in heterodimers, thus
contributing to highly variable clinical phenotypes of HPP [10].
Consequently, genotype–phenotype correlations are difﬁcult to estab-
lish, because most patients are compound heterozygous for missense
mutations and/or are carriers of mutations exhibiting a dominant nega-
tive effect.
Genotype–phenotype correlations have been examined by the use
of site-directed mutagenesis and three dimensional (3D) modeling of
the enzyme [2,10–15]. Most of these studies show an excellent corre-
lation between the severity of the phenotype and residual enzymatic
activities produced in vitro, and/or localization of mutant residues in
the 3D structure, whereas transfection assays may not distinguish
structural mutations from functional ones [13]. To date, all clinical
forms of HPP have been shown to involve TNAP mutations that com-
promise the protein structure. According to 3D modeling studies,
most mutations affect functional domains of the protein, namely the
active site, the calcium binding site, the crown domain, and the
homodimer interface, as well as other regions involved in dimeriza-
tion, tetramerization, or membrane anchoring [13,16,17]. In this con-
text, computational approaches for protein 3D modeling may assist in
establishing genotype–phenotype and structure–function correla-
tions, as well as predicting the structural and/or functional impact
of each mutation.
The goal of the present studywas to identify themutation(s) associ-
atedwith odonto-HPP affectingmonozygotic twin probands, establish a
genotype–phenotype association, and use a 3D modeling approach to
evaluate the impact of each mutation in the TNAP protein structure.
Additionally, we evaluated the expression of mutant protein and its
subcellular localization in dental pulp cells from probands by Western
blotting and immunocytochemistry.
Methods
Subjects
The probands were male monozygotic twins of Caucasian descent
clinically diagnosed with odonto-HPP. Probands and their biological
parents were examined in order to identify potential mutations in
the ALPL gene. The family was provided with study information and
consented to participate (IRB #065/2005). The clinical diagnosis of
odonto-HPP in the probands (by physical and dental examinations,
radiographs, and blood chemistry assays) and subsequent manage-
ment of dental symptoms have been reported previously [18,19].
Brieﬂy, probands (patients A and B), at the age of two, were brought
to the Piracicaba Dental School, University of Campinas, Brazil for
dental evaluation. Parents reported premature exfoliation of the ante-
rior primary teeth, with signs of partial root resorption. Physical ex-
amination and radiographs (long bones, joints, and skull) showed
age-appropriate growth and development. Routine laboratory testing
revealed low serum ALP activity for both probands (patient A: 62 U/L,patient B: 63 U/L; normal range for children 151–471 U/L), while
serum phosphate and calcium levels remained within normal limits
[18–20].
Genotype analyses
Genomic DNA of probands and their parents was isolated from pe-
ripheral blood leukocytes using a Wizard® Genomic DNA Puriﬁcation
Kit (Promega, Madison, WI, USA) following the manufacturer's
instructions.
Primer sequences were designed to amplify all TNAP coding exons
(2–12), as previously reported [21], allowing analysis of the whole
coding sequence, including intron–exon borders. Polymerase chain
reaction (PCR) was performed in a ﬁnal volume of 50 μL with
100 ng of DNA, 30 μM forward and reverse primers, 0.2 mM dNTP
mix (Invitrogen™, Life Technologies, Carlsbad, CA, USA Life Technolo-
gies, Gaithersburg, MD, USA), 0.75 U Gold Tap® Flexi DNA polymer-
ase (Promega), and 1–3 mM MgCl2. Cycle conditions and annealing
temperature were optimized for each primer pair.
PCR products were puriﬁed from agarose gel using GFX PCR DNA
and Gel Band puriﬁcation kit (GE Healthcare, Piscataway, NJ, USA),
according to the manufacturer's instructions. DNA sequence analysis
was performed using the BigDye Terminator v3.1 Cycle Sequencing
Kit and migrated on capillary 3500 Genetic Analyzer (Applied
Biosystems, Foster City, CA, USA). Sequence similarity was performed
using BLASTN [22]. Putative mutations were identiﬁed after multiple
sequence alignment using Clustal W [23] and electropherogram
analysis. The existence of each putative mutation was conﬁrmed by
sequencing DNA from both parents, as well as by a secondary valida-
tion method, i.e. restriction enzyme digestion of DNA or ampliﬁcation
using speciﬁc primers.
Polymerase chain reaction (PCR)
PCR was used additionally to conﬁrm identiﬁed gene mutations
(described above). Primers were designed to amplify alleles with
suspected gene deletion (1318_20delAAC), by using forward primer se-
quences designed with (native TNAP: 5′-GCCCACAGCTCACAACAAC-3′)
or without (1318_20delAAC: 5′-GCCCACAGCTCACAACTAC-3′) the three
base pair AAC deleted. PCR reactions were performed using 5 ng of
DNA template, 0.4 μM each forward and reverse (5′-GTCCACGAGCAGA
ACTACG-3′) primers and LightCycler® FastStart DNA MasterPLUS
SYBER Green I kit 1X (Roche Diagnostics, Penzberg, Germany) in the
LightCycler® 2.0 Instrument (Roche Diagnostics).
Three dimensional (3D) modeling
Three dimensional (3D)models of the native TNAP protein andmu-
tants (p.N440del, p.R152C and p.N440del/p.R152C) were constructed
based on the previously determined 3D structure of humanplacental al-
kaline phosphatase (PLAP) (PDB ID: 1EW2) [17] using SWISS-MODEL
software (http://swissmodel.expasy.org/) [24–26]. These models were
aligned, visualized, and analyzed using the open source software
PyMOL Graphics System Molecular (Version 1.2r3pre, Schrödinger,
LLC) (http://www.pymol.org). Internal contacts for native and mutant
residues in the TNAP structure were analyzed using STING Millennium
software [27] from the Brazilian Enterprise for Agricultural Research
(EMBRAPA) (http://www.nbi.cnptia.embrapa.br/SMS/index_s.html).
Immunoﬂuorescence
Primary dental pulp cells from both probands A and B (genotype:
p.[N440del];[R152C]) and four control individuals (native TNAP)
were obtained as previously reported [20]. Brieﬂy, extracted teeth
were placed in biopsy media, and pulp was harvested by cracking
open the teeth using a dental chisel and hammer and removing the
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digestion with 3 mg/mL collagenase type I and 4 mg/mL dispase
(Gibco®, Invitrogen™, Life Technologies) for 1 h at 37 °C. Cells at
passage four were seeded on coverslips in 24-well cell culture plate
(2 × 104 cells per well) and were cultured in DMEM with FBS 5%
for 24 h. After two washes in phosphate-buffered saline (DPBS,
Invitrogen™, Life Technologies), cells were ﬁxed in 2% paraformalde-
hyde in DPBS for 20 min at room temperature (RT). Blocking for
non-speciﬁc bindingwas performed by incubating with blocking buffer
solution (10% normal donkey serum in DPBS) for 45 min at RT. Subse-
quently, coverslips containing ﬁxed cells were incubated overnight at
4 °C with human alkaline phosphatase/ALPL monoclonal rat antibody
(R&D Systems, Inc., Minneapolis, MN, USA) in DPBS containing 1% nor-
mal donkey serum (Sigma, St. Louis, MO, USA) and 1% bovine serum al-
bumin (BSA, Sigma). Next, coverslips were washed twice in DPBS and
incubated with Alexa Fluor 546 goat anti-rat IgG (Invitrogen™, Life
technologies) for 2 h at RT in the dark. After washing twice with
DPBS, nuclear counterstain was performed by incubation with 0.5 μM
de SYTO® 21 green ﬂuorescent nucleic acid stain (Invitrogen™, Life
Technologies) in DPBS for 2 min at RT. Coverslips were mounted in
the ProLong® Gold antifade reagent (Molecular Probes®, Invitrogen™,
Life Technologies). The subcellular localization in dental pulp cells was
visualized using the Leica TCS SP5 confocal microscope (Leica
Microsystems, Wetzlar, Germany). Negative controls were performed
using the incubation buffer with no primary antibody.Western blot analysis
For extraction of total proteins, primary dental pulp cells, at pas-
sage ﬁve, from probands A and B (genotype: p.[N440del];[R152C])
and four control individuals (native TNAP) were seeded in 100 mm
tissue culture dishes (40 × 104 cells per plate) in Dulbecco's Modiﬁed
Eagle Medium (DMEM; Invitrogen™, Life Technologies) with 10% FBS
for 24 h. Next, medium was changed to 5% FBS supplemented with
50 μg/mL ascorbic acid (AA) and 10 mM β-glycerol phosphate
(βGP) for 7 days, with medium changed every other day. Cells were
washed twice with DPBS, harvested in ice-cold DPBS containing pro-
tease inhibitor cocktail (Sigma) and centrifuged at 850 g. The cell pel-
let was lysed with RIPA buffer (Sigma) containing protease inhibitorFig. 1. Kindred pedigree: Autosomal dominant inheritance of an odontohypophosphatasia
parents are pedigree data, dental symptoms, and serum ALP activity (U/L), as well as resu
measured at the age of diagnosis, where normal values for the adult range are 25–100 U/L
of inheritance. Genetic analysis revealed the mutation 1318-20delAAC, promoting the deleti
and substitution C> at position 454-nt leading to the change of arginine 152 to cysteine (p.R1
genetically evaluated, (†): deceased person.cocktail (Sigma). Total protein concentration was determined by
the Bradford method. Similar amounts of total protein from each
sample (~70 μg) were resolved on 10% SDS-polyacrylamide gel elec-
trophoresis (PAGE) and then transferred to Hybond-ECL nitrocellu-
lose membrane (GE Healthcare). Blots were blocked by incubation
with 3% BSA in Tris buffer saline (TBS, pH 7.6) for 1 h. To detect the
target protein, blots were probed with human alkaline phosphatase/
ALPL rat monoclonal antibody (1:500, R&D Systems, Minneapolis,
MN, USA) and secondary antibodies conjugated to horseradish perox-
idase (1:30,000, ECL Anti-Rat IgG, GE Healthcare) in TBS containing
0.1% Tween 20. All steps of the incubation were performed for 1 h
at room temperature with gentle agitation. The antigen–antibody
complexes were detected by chemiluminescence using SuperSignal®
West Fento Maximum Sensitivity Substrate (Thermo Scientiﬁc, Pierce
Biotechnology, Rockford, IL, USA) for 1 min. Then, chemiluminescent
images were acquired using an acquisition and documentation system
(MicroChemi 4.2 from DNR Bio-Imaging Systems, Israel). Blots
were re-probed with α-tubulin mouse monoclonal antibody (1:500)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and secondary
ECL Anti-Mouse IgG antibodies, (1:20,000). TNAP levels were semi-
quantiﬁed by densitometry using Scion image analysis software
(Scion Corp, Frederick, Maryland) and normalized according to density
of α-tubulin protein.Results and discussion
Genotype–phenotype association in odonto-HPP diagnosed subjects
In the present study, clinical symptoms, laboratory assays, pedi-
gree data, and genomic DNA sequence analysis were used in order
to establish an odonto-HPP genotype–phenotype association, and
these data are summarized in Fig. 1. Tracing the family history, the
mother of the probands (subjects A and B) was asymptomatic, and
her serum ALP activity was found to be normal (51 U/L; normal
range 25–100 U/L). However, the father presented clinical signs of
dental abnormalities including short roots, mild enamel defects,
pulp chamber enlargement, low serum ALP levels (18 U/L; normal
range 25–100 U/L), and reported a familial history of early tooth
loss in his father. Overall, these ﬁndings suggested initially that theclinical phenotype. Summarized here for probands (PA and PB) and their biological
lts of genetic analysis (see Supplementary data). Serum ALP activities reported were
. Dental phenotypes in probands and their father suggest autosomal dominant pattern
on of asparagine (N) at position 440 of the TNAP (p.N440del), was paternally inherited,
52C) was maternally inherited. Abbreviations: (N): normal allele, (na): not clinically or
Fig. 2. Three dimensional models of TNAP dimer andmonomer. (A) Ribbon representa-
tion corresponding to the dimer of native TNAP. The monomer I is shown in purple,
monomer II in light blue, the collagen-binding site in black, and the active site
highlighted by yellow spheres. Localization of residues R152 (highlighted by orange)
and N440 (highlighted by red) are indicated in the model. (B) Ribbon presentation of
superimposed structures of native TNAP (cyan) and mutant p.N440del/p.R152C (light
green). The model was based on the crystal structure of the PLAP monomer (PDB ID:
1E2W), and signal peptide was not included in the 3D model shown here. The active
site is indicated by yellow spheres and the collagen-binding site is highlighted in
black. The residue affected by missense mutation (R152C) is highlighted by orange
spheres. The native N440 residue is indicated by red, while the mutant residue position
(N440del) is indicated by blue arrow. The R152 residue affected by a missense mutation
is located in theα-helix on the surface of themolecule, while N440 residue affected by de-
letion is located in the coil structure of the ﬂexible loop, corresponding to collagen-binding
site in the crown domain. N440 residue deletion promotes the change of coil structure,
affecting neighbor residues (H438, N439 and Y441), localized into the ﬂexible loop
corresponding to collagen-binding site. These ﬁgureswere assembledwith PyMOL Graphics
System Molecular.
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(Fig. 1).
Screening for mutations in the ALPL gene revealed two genetic alter-
ations in the probands (Supplementary data). Firstly, therewas a hetero-
zygous substitution C→T at position 454-nt, leading to the substitution
of cysteine for arginine 152 (p.R152C), an alteration previously described
in this family and found in the mother of the probands [18–20]. The
p.R152C (c.454C>T) missense mutation, associated to other mutation
p.R184W (c.550C>T), has been reported previously in a case of adult
HPP (p.[R152C];[R184W]; SESEP — University of Versailles- Saint
Quentin), whereas a mutation affecting the same codon p.R152H
(c.455G>A) has been described in the mother of a patient with a lethal
clinical formofHPP [28]. p.R152H is believed to be a TNAPpolymorphism
because this alteration was detected in 3 of 168 alleles (frequency of
1.8%) in subjects from a control group with metabolic bone diseases
other than HPP, including osteogenesis imperfecta [29]. It is notable
that p.R152H would be a conservative missense mutation (also termed
a synonymous mutation) in terms of properties of arginine and histi-
dine, while p.R152C would be a non-conservative missense mutation.
Notably, studies have indicated that some ALPL polymorphisms, as
well as compound heterozygous mutations, may play an important
role in HPP severity when associated with additional ALPL mutations
[15,21,29].
The second alteration identiﬁed in the probandswas a heterozygous
gene deletion of three base pair in-frame (AAC) at positions 1318–
1320-nt (c.1318_1320delAAC), leading to deletion of asparagine
(Asn, N) at codon 440 (p.N440del). While the missense mutation de-
scribed above was maternally inherited, the p.N440del was of paternal
origin (Fig. 1).
The genetic alteration 1318_1320delAAC (p.N440del) has not been
reportedpreviously for odonto-HPP or otherHPP types. Clinical dental ab-
normalities and low serum ALP activity in the father, in addition to the
shared p.N440del, strongly suggests a genotype–phenotype correlation
between p.N440del and odonto-HPP in this family. Notably, the probands
(genotype: p.[N440del];[R152C]), whowere compound heterozygous for
the missense mutation (p.R152C) and deletion (p.N440del), present an
early-onset and relatively severe odonto-HPP phenotype, whereas the
father with only one mutation (genotype: p.[N440del];[=]), presented
relatively moderate symptoms with no premature tooth loss and rela-
tively milder enamel phenotype. Thus, our ﬁndings suggest that the
N440 deletion is a pathological genetic alteration, whereas p.R152C
may contribute or predispose to a more severe dental phenotype in
combination with the deletion.
Analysis of 3D models of mutant TNAP proteins
In order to provide insights on potential contribution of each genetic
alteration to enzyme function and the odonto-HPP phenotype, 3D pro-
teinmodeling and computational analysis were used to predict how the
identiﬁed alterations would affect protein tertiary structure. The align-
ment of the 3D models of native TNAP protein and mutants revealed
that the deletion of the N440 residue was predicted to result in protein
conformational changes (Fig. 2). The N440 residue is located in the coil
structure of loop 422–452 (loop 405–435 excluding the signal peptide),
corresponding to a collagen-binding site within the crown domain of
TNAP [13]. N440 residue deletion resulted in the change of this coil
structure, affecting the protein folding pattern as well as the hydrogen
bonding and hydrophobic interactions between neighbor residues
(H438, N439, and Y441) and other regions of the molecule (Figs. 2
and 3). Residues of this coil structure are located in the highly accessible
loop (422–452) within the crown domain that is formed by the inser-
tion of a 60-residue segment (388–448) from each TNAP monomer
[13,17,30]. The functional and structural importance of the crown
domain has been elucidated through building 3Dmodels of the enzyme
based on the structure of human PLAP, and localization of residues
affected by mutation within the speciﬁc domains [13,17,30,31].Results from these studies demonstrated that the crown domain is crit-
ical for isozyme-speciﬁc properties such as non-competitive inhibition,
heat-stability, and allosteric behavior [17,30], as well as dimerization
and homodimer stability, and interactions between TNAP and extracel-
lular matrix proteins including collagens [13,31].
The maternally inherited p.R152C missense mutation was not
predicted to result in signiﬁcant conformational changes to the TNAP
molecule (Fig. 2). On the other hand, differences in internal contacts
established for mutant C152 compared to the native R152 residue
were observed. In the native protein, the R152 residue interacts with
T148, S149, D156, Y178 and H180 residues, however two interactions
are abolished (H180 and Y178), and one interaction with a novel resi-
due (K155) is established in the mutated C152 form (Fig. 3). R152 is a
nonconserved residue located in the α-helix and within a cluster that
Fig. 3. Alterations in amino acid interactions in the p.R152C and p.N440del mutant TNAP proteins. (A) Graphical representation for internal contacts for R152 (native) and C152
(mutant) residues: interactions with T148, S149, D156, Y178 and H180 are observed in the native protein (R152), however two interactions are abolished (H180 and Y178) and
one interaction with a novel residue (K155) is established due to the replacement of R by C residue at 152 position. (B) Graphical representation of internal contacts for N440
residue in the native protein: hydrogen bond and hydrophobic interactions with the H438 residue are observed in the native protein, but these interactions are lost in the protein
affected by deletion of N440 residue. (C) Graphical representation of internal contacts for H438 residue in the native and mutant protein: interactions with D435, N440 and Y441
are observed in native TNAP, while in the protein affected by deletion of N440 residue, all interactions with N440 and charge attractive interaction with D435 are abolished.
(D) Graphical representation of internal contacts for N439 residue in the native and mutant protein: one hydrophobic interaction with L299 is observed in native protein, but this inter-
action is abolished in the protein affected by deletion of N440. Part of themodeled TNAP structure showing internal contacts for C152, R152, N440, H438 and N439 residues are presented
below each graphical representation. Colored lines represent different types of interactions: salmon= hydrogen bond (main chain–main chain); orange = hydrogen bond (side chain–
main chain), light blue = hydrogen bond (side chain–side chain), purple = hydrophobic interaction, gray = aromatic stacking, red = charge repulsive interaction, green = charge
attractive interaction. Graphical representation and analysis for internal contacts was performed using the STING Millennium software [27].
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erally not believed to play an important structural role [13,14,17],
Monet et al. (2001) pointed to a role for R152 residue in the secondary
structure of the protein [13]. For example, mutations affecting residues
on the surface of the molecule may alter the tetramer or homodimer
formation, leading to dysfunctional interactions with other important
players for biological function [8,9].
TNAP enzyme activity may be directly or indirectly affected by
genetic alterations, depending on the nature of interactions between
altered residues and nearby residues and/or critical domains, such as
the active site, ligand-binding site, and homodimer interface [14]. In
the present study, both genetic alterations (p.N440del and p.R152C)
were distant from active site (Fig. 2) and did not appear to directly
affect the catalytic properties of TNAP. In addition, based on the
localization these residues in a 3D model of homodimer (Fig. 2A),
we observed that neither p.R152C nor p.N440del appears to affect
the dimer formation. On the other hand, TNAP activity also could beindirectly affected by incorrect biosynthesis, loss the molecule stabil-
ity, impaired trafﬁcking of TNAP to cell surface, or abnormal interac-
tions with other cellular proteins [31–35], therefore we performed
additional studies to gain further insights as to the mechanism for
loss of ALP activity in these probands.
Expression and localization of mutant TNAP in dental pulp cells
Mutations mapped to different domains of the ALPL, affecting alka-
line phosphatase activity (e.g. p.D306V, p.E235G, p.N170D, p.A179T,
and p.G334D), have been described to exhibit improper folding
and incorrect assembly [32,33,35,36]. Misfolded and incorrectly
assembled proteins are generally recognized and degraded by the
endoplasmic reticulum (ER) quality-control system [33,36]. The ER
quality-control system is crucial for securing the ﬁdelity of gene
expression at the posttranslational level and permits only correctly
folded and completely assembled proteins to proceed to the Golgi,
395L. Martins et al. / Bone 56 (2013) 390–397subsequently to be transported to cell membrane [33]. Therefore,
decreased expression of TNAP mutants on the cell surface may be due
to improper protein folding and incorrect assembly, resulting in the de-
fective transport, accumulation in the early stages of the secretory path-
way and degradation of mutant proteins in a proteasome-dependent
manner [32,33,35,36].
To attempt to deﬁne how molecular defects of TNAP (p.R152C
and p.N440del) may indirectly affect TNAP activity, immunoﬂuores-
cence staining and western blotting analysis were performed in
dental pulp cells obtained from probands and control individuals. Based
on previous studies, TNAP is synthesized as a 66-kDa immature form
with high mannose-type oligosaccharides, which is then converted to
the ~80-kDa mature form bearing complex-type carbohydrate chains,
which after being properly trimmed and terminally glycosylated through
theGolgi apparatus,ﬁnally reaches the plasmamembrane and is exposed
on the cell surface via a GPI anchor [32,35]. Studies have demonstrated
that the 80-kDa mature form, but not the 66-kDa one, is predominantly
expressed on the cell surface. Incorrect posttranslational modiﬁcation
of 66-kDa immature form may lead to formation of disulﬁde-bonded
aggregates in the endoplasmic reticulum, that ultimately do not proceed
to the cell surface [32,34,35].
Here, we analyzed dental pulp cells from probands carrying both
a heterozygous missense mutation (p.R152C) and a heterozygous
deletion (p.N432del) in different alleles. Western blotting analysis
revealed the presence of both the 66-kDa and ~80-kDa forms of TNAPFig. 4. Mutant TNAP protein expression in dental pulp cells. (A) Representative image
showed the TNAP protein expression in primary dental pulp cells from patient A
(PA: lanes 1 and 2) and patient B (PB: lanes 3 and 4) and four controls (Control indi-
viduals: lanes 5, 6, 7, and 8) by Western blotting. Two bands, corresponding to the
major ~80-kDa (glycosylated) and ~66-kDa (non-glycosylated) form of TNAP, were
detected in dental pulp cells from probands and control individuals. However, an
increased level of the 66-kDa form of TNAP versus the 80-kDa was observed in extracts
of total protein from probands' cells, expressing mutant TNAP proteins (PA: 1, 2 and
PB: 3, 4; Genotype: p.[R152C];[N440del]), compared to control cells, expressing the
native TNAP protein (Controls: 5, 6, 7 and 8). (B) The graph shows the percentage of
expression values normalized for each ~80 kDa and ~66 kDa form of TNAP in each
sample. TNAP protein levels (~80 kDa and ~66 kDa) were estimated using Scion
Image software and normalized by α-tubulin protein levels (~55 kDa). Similar results
were obtained in additional experiments.in total protein extracts from probands and control cells (Fig. 4A),
however the ~80-kDa form predominated in control cells, whereas
there was increased ratio of the 66-kDa form (non-glycosylated, imma-
ture form of TNAP) to the 80-kDa (glycosylated or mature form
of TNAP) in probands compared to control cells (Fig. 4B). Furthermore,
immunocytochemistry revealed that TNAP was localized to the cell
surface (and cytoplasm) in control dental pulp cells (with native
TNAP), whereas mutated TNAP protein was more predominantly local-
ized to the perinuclear region and cytoplasm in cells from the probands
(Fig. 5).
We have demonstrated previously that primary periodontal
ligament and dental pulp cells harvested from the same probands
exhibited increased ALPLmRNA, whereas residual ALP activity and abil-
ity to promote mineralization in vitrowere markedly reduced (40% and
50%, respectively) [18,20]. Here, we showed that increased ALPLmRNA
concentration in these cells does not result in increased protein expres-
sion, suggesting that regulatory mechanisms, such as the ER quality-
control system, may be intervening and resulting in defective intracel-
lular transport of mutant TNAP, likely due to retention of a fraction of
mutant TNAP molecules in the intracellular compartment.
Mutations affecting TNAP trafﬁcking have been described previous-
ly. Shibata et al. [35] showed that a homozygous missense mutation
in TNAP affecting the 179 residue (p.A179T), associated with a lethal
hypophosphatasia, exhibited defective folding that affected trafﬁcking
of TNAP molecules, causing only a small fraction of mutated TNAP pro-
tein to reach the cell membrane, presumably due to the formation of
disulﬁde-bonded high-molecular mass aggregates. Intriguingly, cells
expressing mutant TNAP (p.A179T) exhibited residual TNAP activity,
suggesting themutation did not lead to complete inactivation of the en-
zyme [35]. Conversely, Numa et al. [34] showed that the TNAPmutation
(p.V423A), mapped to the collagen-binding domain, had a markedly
reduced alkaline phosphatase activity, but this was not the result of
defective transport, rather suggesting a structural importance of the
crown domain (more speciﬁcally of collagen-binding domain) with
respect to the catalytic function of TNAP.
A novel mutation, p.N440del, localized to the TNAP crown domain
was identiﬁed in the probands in this study. A number of TNAP mis-
sense mutations affecting amino acid residues localized in a ﬂexible
loop corresponding to the collagen-binding region have been identi-
ﬁed in individuals diagnosed with HPP (Table 1). Moreover, Mornet
et al. [13], showed that among 10 mutations localized in the crown
domain and associated with HPP, at least six were located to this
loop, including p.V423A, p.G426C, p.Y436H, p.S445P, p.R450C, and
p.R450H. Interestingly, genetic alterations affecting amino acid resi-
dues in the collagen-binding loop correspond to homozygous severe
forms of HPP or heterozygous mild phenotypes (Table 1), indicating
that this region plays an important, but presently unclear, role in
TNAP function.
It is difﬁcult to assign speciﬁc dysfunctions to each heterozygous
mutation in these probands. Considering the functional and struc-
tural importance of the crown domain, and based on the pedigree,
reduced ALP activity in vivo and in vitro, and predicted alterations
in mutant TNAP structures, we hypothesize that the odonto-HPP
phenotype is associated with the heterozygous deletion of residue
N440, which may indirectly affect the enzyme activity, possibly
from failure to reach a correct conformation, or via alterations in in-
teractions with collagen. On the other hand, based on TNAP protein
expression and immunolocalization, analysis of internal contacts,
and reports in the literature, we propose that the consequences
of heterozygous N440 deletion are intensiﬁed by association
with the heterozygous missense mutation, p.R152C. However,
because the p.R152C mutation was of maternal heritance and
the mother was asymptomatic, we propose that when heterozy-
gous and in the absence of other mutations, this alteration is not
in itself sufﬁcient to signiﬁcantly and deleteriously affect TNAP
function.
Fig. 5. Immunolocalization of TNAP protein in the dental pulp cells. Subcellular localization of TNAP protein in dental pulp cells from a (A) control individual and (B) a proband.
Negative control was performed in the absence of primary antibody and is shown in panel (C). TNAP expression was visualized by red ﬂuorescent staining (Alexa Fluor 546)
using a Leica TCS SP5 confocal microscope (A and B bar = 25 μM; in C bar = 50 μM). Nuclear counterstaining was performed with SYTO® 21 Green Fluorescent Nucleic Acid
Stain and was visualized by green ﬂuorescent staining.
396 L. Martins et al. / Bone 56 (2013) 390–397It remains unclear how particular ALPLmutations cause more severe
clinical forms of HPP, in contrast to mild forms, including odonto-HPP.
Dental tissues have been reported to be highly sensitive to dysregulation
of phosphate and pyrophosphate metabolism [42–44], perhaps indicat-
ing that less deleteriousALPLmutationsmaypreferentially affect the den-
tition, but not the broader skeleton.
Conclusions
We characterized a novel genetic alteration (c.1318_1320delAAC,
p.N440del) in the ALPL gene resulting in odonto-HPP in the probands,
monozygotic twins. Based on pedigree information, clinical symptoms,
genetic analysis, and residual ALP activity, a genotype–phenotype asso-
ciation was established for p.N440del and odonto-HPP in this case. The
heterozygous gene deletion was paternally inherited, and predicted
to alter the loop harboring a collagen-binding site in the TNAP pro-
tein crown domain. In addition to this gene deletion, the probands
feature an p.R152C missense mutation of maternal inheritance,
which was not predicted to alter protein structure, but may contrib-
ute to the more aggressive dental phenotype and reduced ALP activity
observed in probands (p.[N440del];[R152C]) compared to their father
(heterozygous p.N440del). Therefore, we propose that the molecularTable 1
Summary of reported ALPL gene mutations affecting amino acid residues located in the col
Clinical form in patient Base change Amino acid change
Non–standardized nomenclature
Perinatal c.1268T>C V406A
Adult c.1270G>A V407M
Infantile c.1276G>T G409C
Infantile c.1276G>A G409S
Childhood c.1277G>A G409D
Perinatal c.1282C>T R411X
Perinatal c.1283G>C R411P
Odonto-HPP c.1285G>A E412K
Infantile c.1306T>C Y419H
Infantile c.1313A>T H421L
Odonto-HPP c.1318_20delAAC N423del
Adult c.1328C>T, A426V
Infantile/perinatal c.1333T>C S428P
Odonto-HPP c.1349G>A R433H
Infantile/perinatal c.1348C>T R433C
Normal allele or uncharacterized mutation (N), Heterozygous (*), previously described as a
the University of Versailles-Saint Quentin en Yvelines, France (Versailles).
Nucleotide numbering is according to the international recommendation and Weiss et
Non-standardized nomenclature: Amino acid numbering is according toWeiss et al. [4] (the
clature: Amino acid numbering is according to the recommendations to the international rbasis of odonto-HPP phenotype described here is associated with both
p.N440del and p.R152C heterozygous compound mutations.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bone.2013.06.010.
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